This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Steven Isakoff
Introduction
Steven Isakoff is a notable inventor based in Brookline, MA (US). He has made significant strides in the field of cancer treatment through his innovative research and patent contributions. His work focuses on utilizing sonic hedgehog inhibitors in combination with other treatments to enhance therapeutic outcomes for cancer patients.
Latest Patents
Steven Isakoff holds a patent for "Combination treatments with sonic hedgehog inhibitors." This patent outlines methods for treating cancer using a combination of an inhibitor of the sonic hedgehog signaling pathway, such as LDE225, along with radiation and a tumor antigen-specific monoclonal antibody. The patent also discusses the use of a BRAF inhibitor in cases of BRAF inhibitor-resistant cancers. He has 1 patent to his name, showcasing his commitment to advancing cancer treatment methodologies.
Career Highlights
Isakoff is affiliated with The General Hospital Corporation, where he continues to contribute to groundbreaking research in oncology. His work has the potential to change the landscape of cancer treatment, providing new hope for patients facing challenging diagnoses.
Collaborations
Steven Isakoff collaborates with esteemed colleagues, including Francesco Sabbatino and Yangyang Wang. These partnerships enhance the research efforts and broaden the impact of their collective work in the medical field.
Conclusion
In summary, Steven Isakoff's innovative contributions to cancer treatment through his patent and collaborative efforts highlight his dedication to improving patient outcomes. His work exemplifies the importance of research and innovation in the fight against cancer.